Article info

Original research
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication

Authors

  1. Correspondence to Prof. Dr. Jan Tavernier; jan.tavernier{at}vib-ugent.be; Prof. Dr. Sarah Gerlo; sarah.gerlo{at}ugent.be
View Full Text

Citation

Van Den Eeckhout B, Huyghe L, Van Lint S, et al
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication

Publication history

  • Accepted October 17, 2021
  • First published November 12, 2021.
Online issue publication 
November 12, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.